Related Experiment Video
Updated: Sep 10, 2025

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Coregulators determine androgen receptor activity in prostate cancer
Kerim Yavuz1, Nathan A Lack1,2,3
1Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6H 3Z6, Canada.
Androgen receptor (AR) binding in prostate cancer (PCa) changes during disease progression, driven by coregulator proteins. These interactions influence AR
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The androgen receptor (AR) drives most prostate cancer (PCa) by binding to DNA and altering gene expression.
- AR binding sites (cistrome) dynamically change during PCa initiation and progression, influencing disease growth and treatment resistance.
- These cistrome changes are increasingly linked to interactions with AR coregulator proteins, not just chromatin accessibility.
Purpose of the Study:
- To offer a novel perspective on the function of AR coregulators in AR transcriptional activity.
- To examine how AR coregulator interactions evolve throughout different stages of prostate cancer.
- To explore the therapeutic potential of targeting AR coregulators in advanced prostate cancer.
Main Methods:
- This review synthesizes emerging evidence on AR coregulator functions.
- It analyzes how coregulator interactions modulate AR DNA binding and gene activation.
- The review discusses the dynamic nature of the AR cistrome in PCa progression.
Main Results:
- AR coregulators stabilize AR binding to DNA, including low- to moderate-affinity sites.
- Coregulator interactions mediate locus-specific epigenetic modifications that promote transcription.
- Alterations in coregulator proteins are critical in defining normal versus oncogenic AR cistromes and AR-mediated transcription.
Conclusions:
- AR coregulators are pivotal in regulating AR transcriptional programs in prostate cancer.
- Understanding these dynamic coregulator interactions is key to deciphering PCa progression and therapeutic resistance.
- AR coregulators represent promising therapeutic targets for advanced prostate cancer.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
GPCRs Regulate Adenylyl Cylase Activity
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

